L
Lumos Diagnostics Holdings Ltd
ASX:LDX
Lumos Diagnostics Holdings Ltd
ASX:LDX
Price:
0.175
AUD
-7.89%
Market Closed
Market Cap:
AU$138.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Lumos Diagnostics Holdings Ltd
ASX:LDX
|
AU |
|
Sanford Ltd
NZX:SAN
|
NZ |
|
Crescent Biopharma Inc
F:C68
|
US |
|
J
|
Jay Mart PCL
SET:JMART
|
TH |
|
N
|
Novo Nordisk A/S
LSE:0QIU
|
DK |
|
Avanti Feeds Ltd
NSE:AVANTIFEED
|
IN |
|
L
|
L'Oreal SA
F:LOR
|
FR |
|
British Land Company PLC
LSE:BLND
|
UK |
|
Argonaut Gold Inc
TSX:AR
|
US |
|
Digitalbox PLC
LSE:DBOX
|
UK |
Cash Flow Statement
Cash Flow Statement
Lumos Diagnostics Holdings Ltd
Lumos Diagnostics Holdings Ltd
Currency: USD
| Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Stock-Based Compensation |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Cash Interest Paid |
(0)
|
(1)
|
(0)
|
(0)
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Change in Working Capital |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
4
|
|
| Cash from Operating Activities |
(11)
N/A
|
(15)
-40%
|
(18)
-18%
|
(12)
+32%
|
(10)
+22%
|
(9)
+11%
|
1
N/A
|
(1)
N/A
|
(9)
-1 664%
|
(2)
+76%
|
|
| Investing Cash Flow | |||||||||||
| Capital Expenditures |
(8)
|
(10)
|
(4)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(8)
N/A
|
(10)
-17%
|
(4)
+55%
|
(1)
+75%
|
4
N/A
|
4
+1%
|
(0)
N/A
|
(0)
+1%
|
(0)
+45%
|
(0)
-319%
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
47
|
47
|
(10)
|
0
|
0
|
5
|
5
|
6
|
6
|
0
|
|
| Net Issuance of Debt |
16
|
(4)
|
(1)
|
(2)
|
1
|
0
|
(2)
|
(1)
|
(1)
|
(1)
|
|
| Other |
0
|
(18)
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
|
| Cash from Financing Activities |
63
N/A
|
25
-60%
|
(11)
N/A
|
6
N/A
|
1
-90%
|
5
+661%
|
3
-47%
|
5
+98%
|
5
+1%
|
(0)
N/A
|
|
| Change in Cash | |||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
(2)
|
(4)
|
(3)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Net Change in Cash |
44
N/A
|
(1)
N/A
|
(37)
-2 634%
|
(10)
+74%
|
(5)
+49%
|
1
N/A
|
3
+474%
|
4
+20%
|
(5)
N/A
|
(3)
+44%
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
(19)
N/A
|
(25)
-30%
|
(22)
+10%
|
(13)
+40%
|
(10)
+27%
|
(9)
+11%
|
1
N/A
|
(1)
N/A
|
(9)
-1 400%
|
(2)
+74%
|
|
Switch to:
Switch to:
See Also
Discover More
